Neda Razavi is the CEO of iSono Health, a company redefining breast cancer detection through the convergence of AI, robotics, and 3D ultrasound. Under her leadership, iSono is creating a new category of imaging that eliminates
reliance on sonographers, delivers MRI-like 3D breast images in minutes, and brings advanced diagnostics to every clinic. She initially invested in iSono Health after recognizing its transformative potential before the company achieved FDA clearance—and now leads it into commercialization and global expansion. With 25 years of experience bringing innovative medical technologies to patients and clinicians, Neda has launched 65 products across six global
platforms, generating over $9 billion in cumulative revenue. She has held leadership roles at Illumina, Roche, Abbott Laboratories, Medtronic, Baxter Bioscience (now Takeda), Kythera (acquired by Allergan), and Natera, building deep expertise in oncology, women’s health, and diagnostics. At Illumina, Neda served as Clinical Marketing Director, leading a global team of 10 senior marketers and 450 cross-functional collaborators to achieve $1.7B in annual revenue.